Phio Pharmaceuticals Strengthens Governance with New Lead Director
King of Prussia, Pennsylvania – October 31, 2025 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing...
RNA therapeutics
Advertisement
Wave Life Sciences’ RNA Breakthrough Targets Obesity and Liver Disorders
BOSTON, October 29, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology leader in RNA medicines, has...
Novartis Expands RNA Therapeutics Portfolio with Avidity Acquisition
Basel, Switzerland – October 26, 2025: Novartis AG announced its agreement to acquire Avidity Biosciences, a U.S. biotechnology company...
TransCode Reports Positive Phase 1a Results for TTX-MC138 in Metastatic Cancer
BOSTON, Massachusetts, October 14, 2025 — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) today announced encouraging preliminary data from its completed...
Evonik and Ethris Partner to Advance RNA Delivery Solutions Globally
ESSEN/MUNICH, Germany, September 9, 2025 – Evonik and Ethris have entered a strategic partnership to enhance RNA-based therapeutic solutions...
Advertisement
